Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19

Right ventricular (RV) and left ventricular (LV) dysfunction is common in a significant number of hospitalized coronavirus disease 2019 (COVID-19) patients. This study was conducted to assess whether the improved mitochondrial bioenergetics by cardiometabolic drug meldonium can attenuate the develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilskersts, Reinis, Kigitovica, Dana, Korzh, Stanislava, Videja, Melita, Vilks, Karlis, Cirule, Helena, Skride, Andris, Makrecka-Kuka, Marina, Liepinsh, Edgars, Dambrova, Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744985/
https://www.ncbi.nlm.nih.gov/pubmed/35008470
http://dx.doi.org/10.3390/ijms23010045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744985/
https://www.ncbi.nlm.nih.gov/pubmed/35008470
http://dx.doi.org/10.3390/ijms23010045

Ejemplares similares